MedTrace Logo

EVLA and Optimal Timing of Sclerotherapy

NCT04774939 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2021-03-01

No results posted yet for this study

Summary

The aim of the study is to investigate the optimal timing of sclerotherapy for treatment of varicose tributaries on EVLA (endogenous laser ablation) patients.

Conditions

  • Venous Reflux

Interventions

PROCEDURE

Endovenous laser ablation

The aim is to combine the significance of for sclerotherapy at the primary EVLA treatment

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Oulu University Hospital

    collaborator OTHER

  • Tampere University Hospital

    collaborator OTHER

  • Päijänne Tavastia Central Hospital

    collaborator OTHER

  • Satasairaala

    collaborator OTHER

  • Vaasa Central Hospital, Vaasa, Finland

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Harri Hakovirta, Professor · University of Turku

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2027-03-15
Completion
2030-03-15

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774939 on ClinicalTrials.gov